C
Centessa Pharmaceuticals plc D
D
CNTA
17.030
USD
-1.14
(-6.27%)
مغلق
حجم التداول
13,743
الربح لكل سهم
-2
العائد الربحي
-
P/E
-11
حجم السوق
2,245,328,456
الأخبار
العنوان: Centessa Pharmaceuticals plc
القطاع: Healthcare
الصناعة: Biotechnology
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.